NDC 49288-0193
Eucalyptus
Eucalyptus
Eucalyptus is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Eucalyptus Globulus Pollen.
| Product ID | 49288-0193_13c9eea1-38b5-472b-b735-a814ca886718 |
| NDC | 49288-0193 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Eucalyptus |
| Generic Name | Eucalyptus |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1974-03-23 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102223 |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | EUCALYPTUS GLOBULUS POLLEN |
| Active Ingredient Strength | 0 g/mL |
| Pharm Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 49288-0193-1
2 mL in 1 VIAL, MULTI-DOSE (49288-0193-1)
| Marketing Start Date | 1974-03-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 49288-0193-5 [49288019305]
Eucalyptus INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0193-3 [49288019303]
Eucalyptus INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0193-1 [49288019301]
Eucalyptus INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0193-2 [49288019302]
Eucalyptus INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0193-4 [49288019304]
Eucalyptus INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| EUCALYPTUS GLOBULUS POLLEN | .05 g/mL |
OpenFDA Data
Pharmacological Class
- Non-Standardized Pollen Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Pollen [CS]
- Allergens [CS]
NDC Crossover Matching brand name "Eucalyptus" or generic name "Eucalyptus"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-2653 | Eucalyptus | Eucalyptus |
| 36987-2654 | Eucalyptus | Eucalyptus |
| 36987-2655 | Eucalyptus | Eucalyptus |
| 36987-2656 | Eucalyptus | Eucalyptus |
| 36987-2657 | Eucalyptus | Eucalyptus |
| 36987-2658 | Eucalyptus | Eucalyptus |
| 36987-2659 | Eucalyptus | Eucalyptus |
| 36987-2660 | Eucalyptus | Eucalyptus |
| 49288-0193 | Eucalyptus | Eucalyptus |
| 0268-1185 | EUCALYPTUS GLOBULUS POLLEN | Eucalyptus |
| 0268-1186 | EUCALYPTUS GLOBULUS POLLEN | Eucalyptus |
| 0268-1187 | EUCALYPTUS GLOBULUS POLLEN | Eucalyptus |
| 0268-1188 | EUCALYPTUS GLOBULUS POLLEN | Eucalyptus |
| 0268-6712 | EUCALYPTUS GLOBULUS POLLEN | Eucalyptus |
| 0268-6713 | EUCALYPTUS GLOBULUS POLLEN | Eucalyptus |
| 63264-102 | SWIMMERS ITCH GUARD | EUCALYPTUS |
Trademark Results [Eucalyptus]
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.